Science 37 to Report First Quarter 2022 Financial Results on May 9, 2022
April 25 2022 - 7:55AM
Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial
Operating System™ today announced it will report first quarter 2022
financial results before the market opens on Monday, May 9, 2022.
Company management will host a corresponding conference call at
5:00 a.m. Pacific Time / 8:00 a.m. Eastern Time.
Investors interested in listening to the conference call may do
so by dialing (844) 467-7754 for domestic callers or (270) 215-9366
for international callers, followed by Conference ID: 1388417. A
live and archived webcast of the event will be available on the
Investor Relations section of the Science 37 website at
https://investors.science37.com/.
About Science 37
Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to enable
universal access to clinical research—making it easier for patients
and providers to participate from anywhere and helping to
accelerate the development of treatments that impact patient lives.
As a pioneer of decentralized clinical trials, the Science 37 Agile
Clinical Trial Operating System (OS) supports today’s more agile
clinical research designs with its full stack, end-to-end
technology platform and centralized networks of patient
communities, telemedicine investigators, mobile nurses, remote
coordinators, provider communities, and data and devices.
Configurable to enable almost any study type, the Science 37 OS
enables up to 15x faster enrollment, 28% better retention and 3x
more diverse patient population with industry-leading workflow
orchestration, evidence generation and data harmonization. For more
information, visit https://www.science37.com.
Contacts:
MEDIA INQUIRIES:Margie KoomanScience 37Phone:
(984) 377-3737Email: pr@science37.com
INVESTOR RELATIONS:Caroline PaulGilmartin
Groupinvestors@science37.com
Science 37 (NASDAQ:SNCE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Science 37 (NASDAQ:SNCE)
Historical Stock Chart
From Jul 2023 to Jul 2024